Prestrelski Steven

Chief Scientific Officer at XERS; Chief Scientific Officer at XERIS PHARMACEUTICALS INC

Sold, on record
$917k
Dollars the filings state
Form 4 sales
9
Latest Feb 22, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale XERIS PHARMACEUTICALS INCPlan not stated
    Jan 11, 2019 2019

    Sold 2,300 shares

    Prestrelski Steven, Chief Scientific Officer

    Sold 0.5% of holdings487,024 shares leftFiling

  2. 2 Form 4 sale XERIS PHARMACEUTICALS INCPlan not stated
    Apr 11, 2019 +90 days

    Sold 10,000 shares at $9.56 ($96k)

    Prestrelski Steven, Chief Scientific Officer

    Sold 2.1% of holdings ($4.7M position)477,024 shares leftFiling

  3. 3 Form 4 sale XERIS PHARMACEUTICALS INCPlan not stated
    Oct 11, 2019 +183 days

    Sold 27,700 shares at $12.01 ($333k)

    Prestrelski Steven, Chief Scientific Officer

    Sold 5.8% of holdings ($5.7M position)449,324 shares leftFiling

  4. 4 Form 4 sale XERIS PHARMACEUTICALS INCPlan not stated
    Jan 13, 2020 +94 days

    Sold 10,000 shares at $5.50 ($55k)

    Prestrelski Steven, Chief Scientific Officer

    Sold 2.3% of holdings ($2.4M position)421,824 shares left0.8x usual sizeFiling

  5. 5 Form 4 sale XERIS PHARMACEUTICALS INCPlan not stated
    Jan 11, 2021 +364 days

    Sold 10,000 shares at $5.72 ($57k)

    Prestrelski Steven, Chief Scientific Officer

    Sold 2.3% of holdings ($2.4M position)416,824 shares left1x usual sizeFiling

  6. 6 Form 4 sale XERIS PHARMACEUTICALS INCPlan not stated
    Jan 13, 2021 +2 days

    Sold 10,000 shares at $6.01 ($60k)

    Prestrelski Steven, Chief Scientific Officer

    Sold 2.4% of holdings ($2.5M position)406,824 shares left1x usual sizeFiling

  7. 7 Form 4 sale XERIS PHARMACEUTICALS INCPlan not stated
    Apr 12, 2021 +89 days

    Sold 10,000 shares at $4.07 ($41k)

    Prestrelski Steven, Chief Scientific Officer

    Sold 2% of holdings ($2.1M position)496,824 shares left1x usual sizeFiling

  8. 8 Form 4 sale XERSPlan not stated
    Feb 22, 2022 +316 days

    Sold 11,228 shares at $2.42 ($27k)

    Prestrelski Steven, Chief Scientific Officer

    Sold 1.9% of holdings ($1.4M position)569,780 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Prestrelski Steven
Source
Feb 22, 2022Feb 24, 2022XERSChief Scientific OfficerForm 4 sale11,228$27k1.9%Plan not statedSEC
Apr 12, 2021Apr 13, 2021XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale10,000$41k2.0%Plan not statedSEC
Jan 13, 2021Jan 15, 2021XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale10,000$60k2.4%Plan not statedSEC
Jan 11, 2021Jan 12, 2021XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale10,000$57k2.3%Plan not statedSEC
Jan 13, 2020Jan 14, 2020XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale10,000$55k2.3%Plan not statedSEC
Oct 11, 2019Oct 16, 2019XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale27,700$333k5.8%Plan not statedSEC
Apr 11, 2019Apr 12, 2019XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale10,000$96k2.1%Plan not statedSEC
Jan 11, 2019Jan 15, 2019XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale2,3000.5%Plan not statedSEC
Dec 26, 2018Jan 2, 2019XERIS PHARMACEUTICALS INCChief Scientific OfficerForm 4 sale15,720$249k3.1%Plan not statedSEC